Company

Petros Pharmaceuticals, Inc.

Headquarters: New York, NY, United States

Employees: 27

NASDAQ: PTPI -2.75%

Market Cap

$3.0 Million

USD as of Jan. 1, 2024

Market Cap History

Petros Pharmaceuticals, Inc. market capitalization over time

Evolution of Petros Pharmaceuticals, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Petros Pharmaceuticals, Inc.

Detailed Description

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Petros Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: NASDAQ: PTPI wb_incandescent

Details

Headquarters:

1185 Avenue of the Americas

3rd Floor

New York, NY 10036

United States

Phone: 973 242 0005